PRKAA1 and type 2 diabetes mellitus: A recent study evaluated its effect in type 2 diabetes and revealed that Rg1 increased glucose uptake in chronic insulin-treated muscle cells, concomitant with the activation of AMPK [74], suggesting that activation is required for the improvement of insulin sensitivity in these cells.